Mebhydrolin

C₁₉H₂₀N₂ — CID 22530

About Mebhydrolin

Mebhydrolin (PubChem CID 22530) has the molecular formula C₁₉H₂₀N₂ and a molecular weight of 276.38 g/mol. Its IUPAC name is 5-benzyl-2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole.

Molecular Properties

• Compound Name: Mebhydrolin
• PubChem CID: 22530
• Molecular Formula: C₁₉H₂₀N₂
• Molecular Weight: 276.38 g/mol
• Exact Mass: 276.16
• IUPAC Name: 5-benzyl-2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole
• SMILES: CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1
• InChI: InChI=1S/C19H20N2/c1-20-12-11-19-17(14-20)16-9-5-6-10-18(16)21(19)13-15-7-3-2-4-8-15/h2-10H,11-14H2,1H3
• InChIKey: FQQIIPAOSKSOJM-UHFFFAOYSA-N
• XLogP: 3.68
• TPSA: 8.17 Ų
• H-Bond Acceptors: 2
• Rotatable Bonds: 2
• Heavy Atoms: 21
• Complexity: —

Lipinski Rule of Five

Passes Rule of Five

Rule	Value
MW ≤ 500	276.38
LogP ≤ 5	3.68
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	2

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of Mebhydrolin?

The IUPAC name of Mebhydrolin (CID 22530) is 5-benzyl-2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole.

What is the SMILES notation for Mebhydrolin?

The canonical SMILES for Mebhydrolin is CN1CCc2c(c3ccccc3n2Cc2ccccc2)C1.

What is the InChIKey of Mebhydrolin?

The InChIKey is FQQIIPAOSKSOJM-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H20N2/c1-20-12-11-19-17(14-20)16-9-5-6-10-18(16)21(19)13-15-7-3-2-4-8-15/h2-10H,11-14H2,1H3.

What are the key properties of Mebhydrolin?

Mebhydrolin has a molecular weight of 276.38 g/mol, XLogP of 3.68, 2 rotatable bonds, 0 hydrogen bond donors, and 2 hydrogen bond acceptors.

Where does this data come from?

All data for Mebhydrolin is sourced from PubChem (CID 22530), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Sources

• PubChem CID 22530 — identifiers, structure, computed properties (public domain)
• DrugCentral drug card 1643 — approved-drug record (CC BY-SA 4.0)

How this page is built: methodology · editorial policy & corrections.